Skip to content

Effects of Respiratory Muscle Exercises on Glucose Tolerance in Healthy Adults

Effects of Respiratory Muscle Exercises on Glucose Tolerance in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04520763
Enrollment
42
Registered
2020-08-20
Start date
2020-08-20
Completion date
2022-04-21
Last updated
2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Aging, Healthy Diet

Brief summary

To evaluate the acute effects of respiratory muscle exercises vs. a control intervention on blood glucose kinetics in healthy adults after an oral glucose tolerance test.

Interventions

OTHER5min respiratory muscle exercises

5 min of hyperpnea at a target intensity of 60-80% MVV 15-30min after ingestion of 75g of glucose

OTHER15min respiratory muscle exercises

5 min of hyperpnea at a target intensity of 60-70% MVV 15-30min after ingestion of 75g of glucose

Sponsors

Swiss Federal Institute of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

This study consists of four visits to the laboratory, each separated by at least 24 hours and each lasting approximately 2.5h. Total duration for each participant is approximately 2 weeks. The study is conducted in 40 healthy adults (≥ 18 years). The study is a randomized, controlled cross-over trial. We chose a cross-over design in order to test the effects of different respiratory exercises compared to a control intervention in order to minimize variability since each subject serves as his/her own control. Due to the nature of the intervention (respiratory muscle exercises), it is not possible to blind participants to the interventions.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥18 years * Healthy * Non-smoking * Body mass index (BMI): 18.5 - 29.9 kg∙m-2 * Normal lung function * Willing to adhere to study rules

Exclusion criteria

* Known or suspected non-compliance, drug or alcohol abuse * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant * Previous enrolment into the current study * Intake of medications affecting metabolism, the cardiovascular or the respiratory system, or sleep * Acute illness or chronic conditions of the gastrointestinal tract, and health conditions affecting metabolism, the cardiovascular or the respiratory system, or sleep * Pregnancy, breastfeeding, or intention to become pregnant during the study

Design outcomes

Primary

MeasureTime frameDescription
Peak blood glucose concentrationthroughout the study, an expected average of 2 weeks per participantPeak blood glucose concentration will be determined in the three conditions (5min or 15min respiratory muscle exercises or control).
area under the glucose-time curvethroughout the study, an expected average of 2 weeks per participantArea under the glucose-time curve will be determined in the three conditions (5min or 15min respiratory muscle exercises or control).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026